Article
Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.
BMJ open - 5 Jul 2021
Havens Jennifer R, Schaninger Takako, Fraser Hannah, Lofwall Michelle, Staton Michele, Young April M, Hoven Ardis, Walsh Sharon L, Vickerman Peter
Abstract excerpt
OBJECTIVES: The overall goal of the Kentucky Viral Hepatitis Treatment Study (KeY Treat) is to eliminate hepatitis C transmission from a county in Appalachian Kentucky by removing the barriers to accessing hepatitis C virus (HCV) treatment. METHODS/ANALYSIS: KeY Treat is a phase IV, open-label, single-arm clinical trial of sofosbuvir/velpatasvir (SOF/VEL) for the treatment of viraemic HCV infections. Those...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.